Recombinant rabies virus vaccine with molecular adjuvant induces strong immune responses and protection in mice Post author: Post published:October 24, 2023 Post category:uncategorized This study aimed to improve the effectiveness of the rabies vaccine to help alleviate and eliminate the rabies epidemic. You Might Also Like Study finds long COVID leaves a distinct immune signature in the blood April 14, 2026 Restoring brain energy balance reverses advanced Alzheimer’s disease in mouse models January 6, 2026 New European project develops human-based models for brain disorders March 7, 2026